Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > IVIg Intravenous Immuno Globulin Treatment Report
What is IVIg Intravenous Immuno Globulin?

Intravenous Immune Globulin (IVIG) is a human blood product consisting of antibodies which is used to treat immune disorders including myaesthenia gravis and multifocial motor neuropathy. It is sometimes trialed on ALS patients during the diagnostic process to rule out other illnesses. Read more...Click to read more below

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
5 33%
Mild
6 40%
None
4 27%

Most commonly reported side effects

Headaches
8 53%
Weight gain
4 27%
queasiness
2 13%
mild, short lived headache
2 13%
High blood pressure (Hypertension)
1 7%
tired
1 7%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking IVIg Intravenous Immuno Globulin. See all 27 dosages

  as needed 0.5 g monthly 1 g monthly 1.5 g monthly 5 g monthly 10 g monthly 12 g monthly 15 mg monthly 25 g monthly 30 g monthly 15 g every other week 40 g monthly 40 mcg monthly 20 mg every other week 50 mg monthly 60 g monthly 60 mg monthly 65 mg monthly 35 g every other week 90 g monthly 60 g every other week 140 mg monthly 150 mg monthly 156 g monthly 550 mg monthly 1000 g monthly 2000 mg monthly
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking IVIg Intravenous Immuno Globulin (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice
14 37% Doctor's advice: 37%
Course of treatment ended
12 32% Course of treatment ended: 32%
Did not seem to work
11 29% Did not seem to work: 29%
Other
7 18% Other: 18%
Expense
2 5% Expense: 5%
Side effects too severe
2 5% Side effects too severe: 5%

See all 37 patients who’ve stopped taking IVIg Intravenous Immuno Globulin

Currently Taking IVIg Intravenous Immuno Globulin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
3
5
3
4

Stopped Taking IVIg Intravenous Immuno Globulin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
9
2
4
9
3
10

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
15 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
1 7%
Somewhat
5 33%
A little
6 40%
Not at all
3 20%

Cost

Paid out of pocket

$200+
3 20%
$100-199
0 0%
$50-99
0 0%
$25-49
2 13%
< $25
2 13%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.